WebJan 28, 2012 · Expert opinion: Development of CXCR4 antagonists with increased affinity, extended pharmacokinetics and/or pharmacodynamics and with the capacity to … WebApr 9, 2024 · A deeper understanding of the roles of the SDF-1α/CXCR4 axis in MM is necessary for the identification of novel molecular targets and the development of newer drugs and treatment strategies. In this review, the pleiotropic role of SDF-1α/CXCR4 axis and SDF-1α/CXCR4 axis-targeted therapies in MM is summarized.
Small molecule and peptide-based CXCR4 modulators as therapeutic agents ...
WebFeb 24, 2024 · The intensive research on CXCR4, regardless of whether it is for antagonists or agonists, or for HIV-1 or other clinical applications, will ultimately advance our … WebJul 5, 2004 · ALX40-4C is a small peptide inhibitor of the chemokine receptor CXCR4 that can inhibit X4 strains of HIV-1. Prior to the discovery of chemokine receptors as the HIV coreceptors, ALX40-4C was used in phase I/II clinical trials to evaluate its therapeutic potential against HIV-1, making ALX40-4C the first anticoreceptor inhibitor to be tested in … emu war general facts
Neurogenic and neuro-protective potential of a novel …
WebInhibition of CXCR4 signaling may be an important therapeutic strategy in many circumstances including cancer, HIV-1 pathogenesis, and several functions within the … WebOct 5, 2024 · We validated CXCR4 expression based on immunofluorescence in 13 stomach tissue samples including 4 CG, 4 LGIN, 3 HGIN, and 3 GC. The positive rate of … WebXinbing Han, in Advances in Pharmacology, 2014. 2.4.1 Clinical significance of CXCR4. Among chemokine receptors, CXCR4 has drawn increasing attention because of its important role not only in the recruitment of leukocytes to sites of pathology and maintenance of stem cells in a microenvironmental niche leukocyte homing but also in … emuwing pty ltd